See every side of every news story
Get Started
SubscribeLogin
Israel-Hamas Conflict
Eid
Elon Musk
Donald Trump
Social Media
Artificial Intelligence
Tesla
Soccer
World Cup
Apple
European Union
Stock Markets
Natural Disasters
pharmtech.com image

News from pharmtech.com

We’ve assigned a media bias rating of Center to pharmtech.com. You can read more about our methodology here.
If you want to know if pharmtech.com is credible or reliable, look no further. We rank pharmtech.com as High factuality. Find out more about our methodology here.

Information about pharmtech.com

Where is pharmtech.com located?pharmtech.com's Website

Media Bias Ratings

Average Bias Rating:
Center
Center
byAd Fontes Media
Do you diasgree?
Edit bias
Learn more about Media Bias Ratings.

Factuality

Learn more about  Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about  Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Top pharmtech.com News

Sanofi buys US biopharma group Blueprint in $9.1 bln deal
France Economy · France

Sanofi buys US biopharma group Blueprint in $9.1 bln deal

77% Center coverage: 22 sources
See the Story
$HAREHOLDER ALERT: Class Action Attorney Juan Monteverde Investigates the Merger of Vigil Neuroscience, Inc. (NASDAQ: VIGL)
Technology · New York

$HAREHOLDER ALERT: Class Action Attorney Juan Monteverde Investigates the Merger of Vigil Neuroscience, Inc. (NASDAQ: VIGL)

75% Left coverage: 12 sources
See the Story
Teva Celiac Disease Candidate Granted Fast Track Designation by US FDA
FDA · United States

Teva Celiac Disease Candidate Granted Fast Track Designation by US FDA

67% Left coverage: 9 sources
Fast Track designation granted for investigational TEV-53408, an anti-IL-15 antibodyDesignation underscores the potential of TEV-53408, currently undergoing a Phase 2a study for the treatment of celiac diseaseCandidate demonstrates Teva’s commitment to bringing important new treatment options to underserved patient populationsSee the Story

Blindspots

Blindspot:
14 sources

FDA Approves New Moderna COVID-19 Vaccine mNEXSPIKE

Left17%
Center16%
Right67%

FDA Approves New Moderna COVID-19 Vaccine mNEXSPIKE

67% Right coverage: 6 sources
A Phase III trial demonstrated mNEXSPIKE’s non-inferior efficacy compared with Moderna’s original COVID vaccine, Spikevax.Robert F. Kennedy Jr. · United StatesSee the Story

USP Opens Advanced Technology Lab in Maryland

100% Center coverage: 1 sources
The new lab will be used to develop and scale innovations for the production of medicines and to help secure the supply chain.Medical · MarylandSee the Story

Training Centers and eCommerce: A Look Into Federal Equipment Company’s Pharma Innovations

100% Center coverage: 1 sources
How Techceuticals, PharmParts, and smart auction strategies are ushering in a new era of efficiency and innovation for CDMOsInnovationRead Article

Market Demands and Emerging Technologies Shape Outsourcing Models

100% Center coverage: 1 sources
Trends in certain forms of drug delivery, as well as the emergence of artificial intelligence, are playing roles in evolving the nature of partnerships, but there are new types of partnerships gaining steam as well.Artificial IntelligenceRead Article

EMA Is Tackling Vulnerabilities in the Supply Chain of Radiopharmaceuticals

100% Center coverage: 1 sources
EMA has published recommendations to address potential radiopharmaceutical shortages.See the Story

The Role of On-Demand Manufacturing and Derisking in Accelerating Early Clinical Trial Success

100% Center coverage: 1 sources
Small pharmaceutical companies are constantly seeking innovative solutions to streamline early clinical trials. Adaptive clinical trials offer important benefits to sponsors and patients, both from a commercial and ethical standpoint. These trials offer flexibility and efficiency, especially in the early stages, where trial protocols can be adjusted based on interim data, such as introducing new doses or modifying participant sample size. Howeve…Read Article

Novel Cell Lysis Solution: Scaling up viral vector harvest with ease and regulatory compliance

100% Center coverage: 1 sources
Pharmaceutical Technology serves as the connection to bio manufacturing and development, featuring regulatory updates and expert industry news.Read Article

Guidance on Quality Culture Standards

100% Center coverage: 1 sources
Matt Cushing, VP of Quality and Science, Nelson Labs, and Susan J. Schniepp, distinguished fellow at Regulatory Compliance Associates, a Nelson Labs Company, discuss PDA/ANSI Standard 06-2025: Assessment of Quality Culture Guidance Documents, Models, and Tools, which was published in February 2025.ScienceRead Article

Breaking News Topics Related to pharmtech.com

New York State

New York State

New York City

New York City

Innovation

Innovation

United States

United States

Medical

Medical

Artificial Intelligence

Artificial Intelligence

News
For You
SearchBlindspotLocal